Format

Send to

Choose Destination
Am J Cardiol. 1995 Aug 15;76(5):396-8.

Impact of a thrombolysis research trial on time to treatment for acute myocardial infarction in the emergency department.

Author information

1
Cardiology Division, Hennepin County Medical Center, Minneapolis, Minnesota 55415, USA.

Abstract

Because time to treatment in AMI is a critical factor in long-term outcome, it is important that complex trials designed to improve reperfusion therapy do not delay the time to treatment. Participation in the TIMI 5 trial did not significantly prolong our door-to-needle time. These results indicate that, if done carefully, complex, labor-intensive studies can be performed within a reasonable time limit. Care should be taken to design protocols incorporating easy drug preparation, informed consent by the ED, and efficiency of trial initiation.

PMID:
7639167
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center